Serum surfactant protein D is associated with the prognosis in patients with chronic kidney disease

Journal of Cardiovascular Medicine

Volumn 14, Issue 6, 2013, Pages 461-465

  Xie, Fangyi ^a   Wang, Xin ^b   Ding, Zhen ^b   Fan, Peiying ^b   Fan, Liuzhang ^b   Chen, Zhong ^b   Ma, Genshan ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Coronary artery disease; Follow up; Risk factor; Surfactant protein D

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; SURFACTANT PROTEIN D;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; ELISA KIT; FEMALE; GENSINI SCORE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; SMOKING;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY ANGIOGRAPHY; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 84879502738     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32835dbd24     Document Type: Article

References (29)

1. Zhang XH, Lu ZL, Liu L. Coronary heart disease in China. Heart 2008; 94:1126-1131.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
3. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2006; 151:492-500. (Pubitemid 43144756)
4. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 2009; 20:2617-2624.
5. Holmskov U, Teisner B, Willis AC, Reid KB, Jensenius JC. Purification and characterization of a bovine serum lectin (CL-43) with structural homology to conglutinin and SP-D and carbohydrate specificity similar to mannan-binding protein. J Biol Chem 1993; 268:10120- 10125. (Pubitemid 23150190)
6. Kingma PS, Whitsett JA. In defense of the lung: surfactant protein A and surfactant protein D. Curr Opin Pharmacol 2006; 6:277-283. (Pubitemid 43670905)
7. Endo S, Sato N, Nakae H, et al. Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ARDS. Res Commun Mol Pathol Pharmacol 2002; 111:245-251. (Pubitemid 38812226)
8. Takahashi H, Shiratori M, Kanai A, Chiba H, Kuroki Y, Abe S. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006; 11:S51-S54.
9. Dahl M. Biomarkers for chronic obstructive pulmonary disease: surfactant protein D and C-reactive protein. Am J Respir Crit Care Med 2008; 177:1177-1178. (Pubitemid 351860923)
10. Sims MW, Beers MF, Ahya VN, et al. Lung Transplant Outcomes Group. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest 2011; 140:489-496.
11. Kongchanagul A, Suptawiwat O, Boonarkart C, et al. Decreased expression of surfactant protein D mRNA in human lungs in fatal cases of H5N1 avian influenza. J Med Virol 2011; 83:1410-1417.
12. Kawasaki Y, Endo K, Suyama K, et al. Serum SP-D levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. Pediatr Pulmonol 2011; 46:18-22.
13. Snyder GD, Oberley-Deegan RE, Goss KL, et al. Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 2008; 294:H2053-H2059.
14. Hill J, Heslop C, Man SF, et al. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J 2011; 32:1918- 1925.
15. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51:606. (Pubitemid 13187192)
16. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17:2937-2944. (Pubitemid 44484685)
17. Leth-Larsen R, Nordenbaek C, Tornoe I, et al. Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia small star, filled. Clin Immunol 2003; 108:29-37. (Pubitemid 36809213)
18. Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007; 212:381- 416. (Pubitemid 46825244)
19. Ohya M, Nishitani C, Sano H, et al. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 2006; 45:8657-8664. (Pubitemid 44078886)
20. Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, Kuroki Y. Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem 2000; 275:22442-22451. (Pubitemid 30621832)
21. Janssen WJ, McPhillips KA, Dickinson MG, et al. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am J Respir Crit Care Med 2008; 178:158- 167. (Pubitemid 351957774)
22. Vandivier RW, Ogden CA, Fadok VA, et al. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol 2002; 169:3978-3986.
23. Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, Holmskov U. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 2000; 164:5866-5870. (Pubitemid 30389831)
24. Stahlman MT, Gray ME, Hull WM, Whitsett JA. Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J Histochem Cytochem 2002; 50:651-660. (Pubitemid 34437558)
25. Soerensen CM, Nielsen OL, Willis A, Heegaard PM, Holmskov U. Purification, characterization and immunolocalization of porcine surfactant protein D. Immunology 2005; 114:72-82. (Pubitemid 40030295)
26. Herías MV, Hogenkamp A, van Asten AJ, Tersteeg MH, van Eijk M, Haagsman HP. Expression sites of the collectin SP-D suggest its importance in first line host defence: power of combining in situ hybridisation, RT-PCR and immunohistochemistry. Mol Immunol 2007; 44:3324-3332. (Pubitemid 46695753)
27. Sorensen GL, Madsen J, Kejling K, et al. Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol 2006; 290:H2286-H2294. (Pubitemid 43846055)
28. Sørensen GL, Hjelmborg JB, Kyvik KO, et al. Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1010-L1017. (Pubitemid 43725064)
29. Hoegh SV, Sorensen GL, Tornoe I, et al. Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology 2010; 215:314-320.